Related references
Note: Only part of the references are listed.p16 loss rescues functional decline of Brca1-deficient mammary stem cells
Alexandria Scott et al.
CELL CYCLE (2017)
BRCA1-hapoinsufficiency: Unraveling the molecular and cellular basis for tissue-specific cancer
Maja Sedic et al.
CELL CYCLE (2016)
Persistent Activation of NF-κB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage
Andrea Sau et al.
CELL STEM CELL (2016)
RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers
Emma Nolan et al.
NATURE MEDICINE (2016)
A BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer
Niamh E. Buckley et al.
ONCOTARGET (2016)
Minireview: Progesterone Regulation of Proliferation in the Normal Human Breast and in Breast Cancer: A Tale of Two Scenarios?
Heidi N. Hilton et al.
MOLECULAR ENDOCRINOLOGY (2015)
Haploinsufficiency for BRCA1 leads to cell-type-specific genomic instability and premature senescence
Maja Sedic et al.
NATURE COMMUNICATIONS (2015)
Genome-wide analysis reveals a role for BRCA1 and PALB2 in transcriptional co-activation
Alessandro Gardini et al.
EMBO JOURNAL (2014)
BRCA1 haploinsufficiency for replication stress suppression in primary cells
Shailja Pathania et al.
NATURE COMMUNICATIONS (2014)
Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Womens Health Initiative Observational Study
Rowan T. Chlebowski et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
The sex hormone system in carriers of BRCA1/2 mutations: a case-control study
Martin Widschwendter et al.
LANCET ONCOLOGY (2013)
Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation
F. Bai et al.
ONCOGENE (2013)
BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment Implications for breast cancer prevention with antioxidant therapies
Ubaldo E. Martinez-Outschoorn et al.
CELL CYCLE (2012)
BRCA1, Hormone, and Tissue-Specific Tumor Suppression
Yanfen Hu
International Journal of Biological Sciences (2012)
Non-Overlapping Progesterone Receptor Cistromes Contribute to Cell-Specific Transcriptional Outcomes
Christine L. Clarke et al.
PLOS ONE (2012)
BRCA1 Counteracts Progesterone Action by Ubiquitination Leading to Progesterone Receptor Degradation and Epigenetic Silencing of Target Promoters
Veronica Calvo et al.
CANCER RESEARCH (2011)
Genetic Predisposition Directs Breast Cancer Phenotype by Dictating Progenitor Cell Fate
Theresa A. Proia et al.
CELL STEM CELL (2011)
Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy
Valerie Beral et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Oral Contraceptive Use and Breast Cancer: A Prospective Study of Young Women
David J. Hunter et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
BRCA1 negatively regulates formation of autophagic vacuoles in MCF-7 breast cancer cells
Juan M. Esteve et al.
EXPERIMENTAL CELL RESEARCH (2010)
Oxidative stress, inflammation, and cancer How are they linked?
Simone Reuter et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Mechanisms of Progesterone Receptor Inhibition of Inflammatory Responses in Cellular Models of Breast Cancer
Sakiko Kobayashi et al.
MOLECULAR ENDOCRINOLOGY (2010)
Altered Proliferation and Differentiation Properties of Primary Mammary Epithelial Cells from BRCA1 Mutation Carriers
Laura N. Burga et al.
CANCER RESEARCH (2009)
DNA Replication Licensing and Progenitor Numbers Are Increased by Progesterone in Normal Human Breast
J. Dinny Graham et al.
ENDOCRINOLOGY (2009)
Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers
Elgene Lim et al.
NATURE MEDICINE (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
OPINION Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Veronique Baud et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
Da Wei Huang et al.
NUCLEIC ACIDS RESEARCH (2009)
Shared principles in NF-κB signaling
Matthew S. Hayden et al.
CELL (2008)
Progesterone receptor inhibits aromatase and inflammatory response pathways in breast cancer cells via ligand-dependent and ligand-independent mechanisms
Daniel B. Hardy et al.
MOLECULAR ENDOCRINOLOGY (2008)
BRCA1 regulates human mammary stem/progenitor cell fate
Suling Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
IκB kinase a kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells
Yixue Cao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist
Aleksandra Jovanovic Poole et al.
SCIENCE (2006)
Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression
D. S. Basseres et al.
ONCOGENE (2006)
Progesterone blocks estrogen-induced DNA synthesis through the inhibition of replication licensing
Haiyan Pan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Estrogen receptor-alpha and progesterone receptor are expressed in label-retaining mammary epithelial cells that divide asymmetrically and retain their template DNA strands
Brian W. Booth et al.
BREAST CANCER RESEARCH (2006)
The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells
YX Ma et al.
MOLECULAR ENDOCRINOLOGY (2006)
BRCA1 regulates gene expression for orderly mitotic progression
I Bae et al.
CELL CYCLE (2005)
Depletion of BRCA1 impairs differentiation but enhances proliferation of mammary epithelial cells
S Furuta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Revealing progesterone's role in uterine and mammary gland biology: Insights from the mouse
R Fernandez-Valdivia et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2005)
Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A
PA Mote et al.
GENES CHROMOSOMES & CANCER (2004)
Increased progesterone receptor expression in benign epithelium of BRCA1-related breast cancers
TA King et al.
CANCER RESEARCH (2004)
BRCA1 induces antioxidant gene expression and resistance to oxidative stress
I Bae et al.
CANCER RESEARCH (2004)
Hallmarks of 'BRCAness' in sporadic cancers
N Turner et al.
NATURE REVIEWS CANCER (2004)
Senescence aging, and malignant transformation mediated by p53 in mice lacking the Brcal full-length isoform
L Cao et al.
GENES & DEVELOPMENT (2003)
Cancer susceptibility and the functions of BRCA1 and BRCA2
AR Venkitaraman
CELL (2002)
Selective activation of NF-κB subunits in human breast cancer:: potential roles for NF-κB2/p52 and for Bcl-3
PC Cogswell et al.
ONCOGENE (2000)
Share Paper
